| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA244261
Max Phase: Preclinical
Molecular Formula: C34H38I2N2O6
Molecular Weight: 570.69
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: COc1cc2cc[n+](C)c(Cc3ccc(Cc4c5c(OC)c(OC)c(OC)cc5cc[n+]4C)cc3)c2c(OC)c1OC.[I-].[I-]
Standard InChI: InChI=1S/C34H38N2O6.2HI/c1-35-15-13-23-19-27(37-3)31(39-5)33(41-7)29(23)25(35)17-21-9-11-22(12-10-21)18-26-30-24(14-16-36(26)2)20-28(38-4)32(40-6)34(30)42-8;;/h9-16,19-20H,17-18H2,1-8H3;2*1H/q+2;;/p-2
Standard InChI Key: JBMDQWPWTLSICG-UHFFFAOYSA-L
Associated Targets(non-human)
Small conductance calcium-activated potassium channel 260 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 570.69 | Molecular Weight (Monoisotopic): 570.2719 | AlogP: 4.88 | #Rotatable Bonds: 10 |
| Polar Surface Area: 63.14 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
| #RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: -4.32 | CX LogD: -4.32 |
| Aromatic Rings: 5 | Heavy Atoms: 42 | QED Weighted: 0.22 | Np Likeness Score: 0.51 |
References
| 1. Graulich A, Dilly S, Farce A, Scuvée-Moreau J, Waroux O, Lamy C, Chavatte P, Seutin V, Liégeois JF.. (2007) Synthesis and radioligand binding studies of bis-isoquinolinium derivatives as small conductance Ca(2+)-activated K(+) channel blockers., 50 (21): [PMID:17867663] [10.1021/jm070412j] |
Source
Source(1):